Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15,352 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anatomic patterns and clinical significance of gastrocolic trunk of Henlé in laparoscopic right colectomy for colon cancer: Results of the HeLaRC trial.
He Z, Yang C, Diao D, Wu D, Fingerhut A, Sun Y, Gao Y, Wang N, Li A, Tong W, Ding P, Xiao Y, Zhou X, Song Z, Yan S, Yao H, Meng W, Huang K, Zhou D, Zhu A, Wang H, Zhou Y, Li X, Kang L, Zhao X, Su H, Zheng M, Ye K, Wang Q, Guo Y, Lu Y, Feng B. He Z, et al. Among authors: li x, li a. Int J Surg. 2022 Aug;104:106718. doi: 10.1016/j.ijsu.2022.106718. Epub 2022 Jun 17. Int J Surg. 2022. PMID: 35724803 Free article.
Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial.
Xu L, Su X, He Z, Zhang C, Lu J, Zhang G, Sun Y, Du X, Chi P, Wang Z, Zhong M, Wu A, Zhu A, Li F, Xu J, Kang L, Suo J, Deng H, Ye Y, Ding K, Xu T, Zhang Z, Zheng M, Xiao Y; RELARC Study Group. Xu L, et al. Among authors: li f. Lancet Oncol. 2021 Mar;22(3):391-401. doi: 10.1016/S1470-2045(20)30685-9. Epub 2021 Feb 12. Lancet Oncol. 2021. PMID: 33587893 Clinical Trial.
Rationale and design of a prospective, multicenter, phase II clinical trial of safety and efficacy evaluation of long course neoadjuvant chemoradiotherapy plus tislelizumab followed by total mesorectal excision for locally advanced rectal cancer (NCRT-PD1-LARC trial).
Yang Z, Zhang X, Zhang J, Gao J, Bai Z, Deng W, Chen G, An Y, Liu Y, Wei Q, Han J, Li A, Liu G, Sun Y, Kong D, Yao H, Zhang Z. Yang Z, et al. Among authors: li a. BMC Cancer. 2022 Apr 27;22(1):462. doi: 10.1186/s12885-022-09554-9. BMC Cancer. 2022. PMID: 35477432 Free PMC article.
15,352 results
You have reached the last available page of results. Please see the User Guide for more information.